🟢 Connect Biopharma is trading 6.1% up today amid biopharma rally after positive melanoma vaccine results

Connect Biopharma is trading 6.1% up now at $2.61, with the move appearing sector-driven after positive Phase 3 melanoma vaccine results from Moderna and Merck.

• No new company-specific announcement was identified on August 20, 2026.
• Its investor-relations page lists the latest release as August 12, covering second-quarter results, completed Phase 2 asthma/COPD enrollment, and September topline data expectations.
• The provided XBI gain of 3.73% is consistent with the broad biopharma rally.